Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Depreciation & Amortization (CF) (2022 - 2025)

Historic Depreciation & Amortization (CF) for Zentalis Pharmaceuticals (ZNTL) over the last 4 years, with Q3 2025 value amounting to $160000.0.

  • Zentalis Pharmaceuticals' Depreciation & Amortization (CF) fell 5015.58% to $160000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $910000.0, marking a year-over-year decrease of 2845.91%. This contributed to the annual value of $1.3 million for FY2024, which is 714.29% down from last year.
  • According to the latest figures from Q3 2025, Zentalis Pharmaceuticals' Depreciation & Amortization (CF) is $160000.0, which was down 5015.58% from $160000.0 recorded in Q2 2025.
  • Over the past 5 years, Zentalis Pharmaceuticals' Depreciation & Amortization (CF) peaked at $375000.0 during Q3 2022, and registered a low of $160000.0 during Q2 2025.
  • In the last 4 years, Zentalis Pharmaceuticals' Depreciation & Amortization (CF) had a median value of $327000.0 in 2024 and averaged $308466.7.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first soared by 933.33% in 2024, then tumbled by 5107.03% in 2025.
  • Zentalis Pharmaceuticals' Depreciation & Amortization (CF) (Quarter) stood at $326000.0 in 2022, then dropped by 7.98% to $300000.0 in 2023, then increased by 9.33% to $328000.0 in 2024, then tumbled by 51.22% to $160000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $160000.0 in Q3 2025, compared to $160000.0 in Q2 2025 and $262000.0 in Q1 2025.